Suppr超能文献

贡德尔大学医院内科病房应激性溃疡药物预防使用情况评估。

Assessment of pharmacologic prophylaxis use against stress ulcer in the medical wards of University of Gondar Hospital.

作者信息

Horsa Boressa Adugna, Ayele Yohanes, Ayalew Mohammed Biset

机构信息

Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

Department of Clinical Pharmacy, School of Pharmacy, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.

出版信息

SAGE Open Med. 2019 Feb 2;7:2050312119827409. doi: 10.1177/2050312119827409. eCollection 2019.

Abstract

BACKGROUND

Critically ill patients with moderate-to-severe physiologically stressful event are at high risk of developing stress ulcers. The use of pharmacological prophylaxis significantly reduces the incidence of stress ulcer in high-risk patients.

OBJECTIVE

The aim of this study was to assess the use of pharmacological prophylaxis for stress ulcer in the medical wards of University of Gondar Hospital.

METHODS

A cross-sectional study design was used. In total, 234 patients were selected through simple random sampling technique. The risk of stress ulcer development was assessed using Evidence-Based Medicine Guideline for stress ulcer prepared by Orlando Regional Medical Center. SPSS version 21 was used for data analysis.

RESULT

The most common acute risk factor to stress ulcer was coagulopathy (18.4%), followed by hypoperfusion (9.8%). The concomitant non-steroidal anti-inflammatory drug use (16.7%), mild-to-moderate brain or spinal cord injury (11.1%), and concomitant or recent corticosteroid use (9.4%) were frequently seen risk factors that necessitate administration of a prophylaxis. In total, 82 (35%) study participants were given stress ulcer prophylaxis, among which 52 (63.4%) were given without indication. The most commonly used drug class in the prevention of stress ulcer was proton pump inhibitors (76/82, 92.7%). In total, 43 (18.4%) study subjects were not given stress ulcer prophylaxis while there was clear indication. Patients with a long hospital stay and a diagnosis of central nervous system disorders had significant risk for inappropriate stress ulcer prophylaxis use.

CONCLUSION

In this study, inappropriate use of prophylaxis for stress ulcer was common. The higher proportion of inappropriateness was due to the use of stress ulcer prophylaxis while there was no enough indication. We recommend future researchers to assess the cost and impact of inappropriate stress ulcer prophylaxis use, and the physicians should be adherent to the standard guidelines.

摘要

背景

患有中度至重度生理应激事件的重症患者发生应激性溃疡的风险很高。使用药物预防可显著降低高危患者应激性溃疡的发生率。

目的

本研究旨在评估贡德尔大学医院内科病房对应激性溃疡的药物预防使用情况。

方法

采用横断面研究设计。通过简单随机抽样技术共选取234例患者。使用奥兰多地区医疗中心制定的应激性溃疡循证医学指南评估发生应激性溃疡的风险。采用SPSS 21版进行数据分析。

结果

应激性溃疡最常见的急性危险因素是凝血功能障碍(18.4%),其次是灌注不足(9.8%)。常见的需要进行预防的危险因素包括同时使用非甾体抗炎药(16.7%)、轻度至中度脑或脊髓损伤(11.1%)以及同时或近期使用皮质类固醇(9.4%)。共有82例(35%)研究参与者接受了应激性溃疡预防,其中52例(63.4%)是在无指征的情况下给予的。预防应激性溃疡最常用的药物类别是质子泵抑制剂(76/82,92.7%)。共有43例(18.

相似文献

1
Assessment of pharmacologic prophylaxis use against stress ulcer in the medical wards of University of Gondar Hospital.
SAGE Open Med. 2019 Feb 2;7:2050312119827409. doi: 10.1177/2050312119827409. eCollection 2019.
5
Stress ulcer prophylaxis in hospitalized patients not in intensive care units.
Am J Health Syst Pharm. 2007 Jul 1;64(13):1396-400. doi: 10.2146/ajhp060393.
7
Overuse of proton pump inhibitors for stress ulcer prophylaxis in Jordan.
Int J Clin Pharmacol Ther. 2016 Aug;54(8):597-602. doi: 10.5414/CP202533.
8
INTENSIVE CARE UNIT PRESCRIPTIONS MUST FIT RISK FACTORS TO PREVENT STRESS ULCER BLEEDING.
Arq Bras Cir Dig. 2022 Jan 5;34(3):e1587. doi: 10.1590/0102-672020210003e1587. eCollection 2022.
10
Inappropriate continuation of stress ulcer prophylactic therapy after discharge.
Ann Pharmacother. 2007 Oct;41(10):1611-6. doi: 10.1345/aph.1K227. Epub 2007 Sep 11.

引用本文的文献

1
Insights into stress ulcer prophylaxis among non-critically ill patients: a tertiary hospital perspective from Sudan.
J Pharm Health Care Sci. 2025 Aug 11;11(1):71. doi: 10.1186/s40780-025-00483-w.
3
An Updated Review and a Case Report: Stress Ulcer Prophylaxis.
Cureus. 2024 May 21;16(5):e60811. doi: 10.7759/cureus.60811. eCollection 2024 May.
5
Adherence to a stress ulcer prophylaxis protocol by critically ill patients: a prospective cohort study.
Rev Bras Ter Intensiva. 2020 Mar;32(1):37-42. doi: 10.5935/0103-507x.20200007. Epub 2020 May 8.

本文引用的文献

1
Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients.
N Engl J Med. 2018 Jun 28;378(26):2506-2516. doi: 10.1056/NEJMra1605507.
4
Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials.
Intensive Care Med. 2018 Jan;44(1):1-11. doi: 10.1007/s00134-017-5005-8. Epub 2017 Dec 4.
5
Impact of targeted educational interventions on appropriateness of stress ulcer prophylaxis in critically ill adults.
Pharm Pract (Granada). 2017 Jul-Sep;15(3):948. doi: 10.18549/PharmPract.2017.03.948. Epub 2017 Aug 15.
10
Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries.
Acta Anaesthesiol Scand. 2015 May;59(5):576-85. doi: 10.1111/aas.12508.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验